Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK MASK observational pilot study

著录项

• 来源
  《Allergy》 |2018年第9期|共12页
• 作者

  Bousquet J.; Devillier P.; Arnavielhe S.; Bedbrook A.; Alexis‐Alexandre G.; Eerd M.; Murray R.; Canonica G. W.; Illario M.; Menditto E.; Passalacqua G.; Stellato C.; Triggiani M.; Carreiro‐Martins P.; Fonseca J.; Morais Almeida M.; Nogueira‐Silva L.; Pereira A. M.; Todo Bom A.; Bosse I.; Caimmi D.; Demoly P.; Fontaine J. F.; Just J.; Onorato G. L.; Kowalski M. L.; Kuna P.; Samolinski B.; Anto J. M.; Mullol J.; Valero A.; Tomazic P. V.; Bergmann K. C.; Keil T.; Klimek L.; M?sges R.; Shamai S.; Zuberbier T.; Murphy E.; McDowall P.; Price D.; Ryan D.; Sheikh A.; Chavannes N. H.; Fokkens W. J.; Kvedariene V.; Valiulis A.; Bachert C.; Hellings P. W.; Kull I.; Melen E.; Wickman M.; Bindslev‐Jensen C.; Eller E.; Haahtela T.; Papadopoulos N. G.; Annesi‐Maesano I.; Bewick M.; Bosnic‐Anticevich S.; Cruz A. A.; De Vries G.; Gemicioglu B.; Larenas‐Linnemann D.; Laune D.; Mathieu‐Dupas E.; OHehir R. E.; Pfaar O.; Portejoie F.; Siroux V.; Spranger O.; Valovirta E.; VandenPlas O.; Yorgancioglu A.;

  展开▼
• 作者单位

  Contre les MAladies Chroniques Pour un VIeillissement Actif en FranceMACVIA‐FranceMontpellier France;

  Laboratoire de Pharmacologie Respiratoire UPRES EA220Suresnes ‐ Université Versailles Saint;

  KyomedMontpellier France;

  Contre les MAladies Chroniques Pour un VIeillissement Actif en FranceMACVIA‐FranceMontpellier France;

  EZYMontpellier France;

  Peercode BVGerdermalsen The Netherlands;

  Medical Communications ConsultantMedScript LtdDundalk Ireland;

  Allergy and Respiratory DiseasesIRCCS San Martino‐IST‐University of GenoaGenoa Italy;

  Division for Health InnovationCampania Region and Federico II University Hospital Naples (R&

  D and;

  Center of PharmacoeconomicsUniversity of Naples Federico IINaples Italy;

  Allergy and Respiratory DiseasesIRCCS San Martino‐IST‐University of GenoaGenoa Italy;

  Department of Medicine Surgery and Dentistry “Scuola Medica Salernitana”University of;

  Department of Medicine Surgery and Dentistry “Scuola Medica Salernitana”University of;

  Servicio de ImunoalergologiaCentro Hospitalar de Lisboa CentralLisbon Portugal;

  Faculdade de MedicinaUniversidade do PortoPorto Portugal;

  Rhinology Unit &

  Smell ClinicUniversity of BarcelonaBarcelona Spain;

  Department of Internal MedicineCentro Hospitalar Sao JoaoPorto Portugal;

  Allergy UnitPorto Portugal;

  ImunoalergologiaUniversity of CoimbraCoimbra Portugal;

  AllergistLa Rochelle France;

  CHU de MontpellierSorbonne UniversitésParis France;

  CHU de MontpellierSorbonne UniversitésParis France;

  AllergistReims France;

  Allergology DepartmentSorbonne UniversitésParis France;

  Contre les MAladies Chroniques Pour un VIeillissement Actif en FranceMACVIA‐FranceMontpellier France;

  Department of Immunology Rheumatology and AllergyMedical University of LodzLodz Poland;

  Division of Internal MedicineMedical University of LodzLodz Poland;

  Department of Prevention of Environmental Hazards and AllergologyMedical University of WarsawWarsaw;

  ISGLoBALCentre for Research in Environmental Epidemiology (CREAL)Barcelona Spain;

  Rhinology Unit &

  Smell ClinicUniversity of BarcelonaBarcelona Spain;

  Pneumology and Allergy Department Hospital Cl?nicUniversity of BarcelonaBarcelona Spain;

  Department of ENTMedical University of GrazGraz Austria;

  Comprehensive Allergy‐Centre‐CharitéCharité Universitatsmedizin BerlinBerlin Germany;

  Institute of Social Medicine Epidemiology and Health EconomicsCharité—UniversitatsmedizinBerlin;

  Center for Rhinology and AllergologyWiesbaden Germany;

  Institute of Medical Statistics and Computational BiologyUniversity of CologneCologne Germany;

  Institute of Medical Statistics and Computational BiologyUniversity of CologneCologne Germany;

  Comprehensive Allergy‐Centre‐CharitéCharité Universitatsmedizin BerlinBerlin Germany;

  Newcastle OHSThe Newcastle upon Tyne NHS Foundation Hospitals TrustNewcastle upon Tyne UK;

  Newcastle OHSThe Newcastle upon Tyne NHS Foundation Hospitals TrustNewcastle upon Tyne UK;

  Observational and Pragmatic Research InstituteSingapore City Singapore;

  Allergy and Respiratory Research GroupUniversity of EdinburghEdinburgh UK;

  Asthma UK Centre for Applied ResearchThe University of EdinburghEdinburgh UK;

  Department of Public Health and Primary CareLeiden University Medical CenterLeiden The Netherlands;

  Department of OtorhinolaryngologyAcademic Medical CentreAmsterdam The Netherlands;

  Clinic of Infectious Chest Diseases Dermatology and AllergologyVilnius UniversityVilnius Lithuania;

  Vilnius University Clinic of Children's Diseases and Public Health InstituteVilnius Lithuania;

  ENT DepartmentGhent University HospitalGhent Belgium;

  EuforeaBrussels Belgium;

  Department of Clinical Science and EducationKarolinska InstitutetStockholm Sweden;

  Department of Clinical Science and EducationKarolinska InstitutetStockholm Sweden;

  SodersjukhusetSachs' Children and Youth HospitalStockholm Sweden;

  Department of Dermatology and Allergy CentreOdense University HospitalOdense Denmark;

  Department of Dermatology and Allergy CentreOdense University HospitalOdense Denmark;

  Skin and Allergy HospitalHelsinki University HospitalHelsinki Finland;

  Center for Pediatrics and Child HealthUniversity of ManchesterManchester UK;

  EPAR U707 INSERMParis France;

  i Q4U Consultants LtdLondon UK;

  Woolcock Institute of Medical ResearchUniversity of SydneySydney NSW Australia;

  ProAR—Nucleo de Excelencia em AsmaFederal University of BahiaSalvador Brazil;

  Peercode BVGerdermalsen The Netherlands;

  Department of Pulmonary DiseasesIstanbul UniversityIstanbul Turkey;

  Center of Excellence in Asthma and AllergyHospital Médica SurMexico City Mexico;

  KyomedMontpellier France;

  KyomedMontpellier France;

  Department of Allergy Immunology and Respiratory MedicineMonash UniversityMelbourne Vic. Australia;

  Center for Rhinology and AllergologyWiesbaden Germany;

  Contre les MAladies Chroniques Pour un VIeillissement Actif en FranceMACVIA‐FranceMontpellier France;

  INSERMUniversité Joseph FourierGrenoble France;

  Global Allergy and Asthma Platform GAAPPVienna Austria;

  Department of Lung Diseases and Clinical AllergologyUniversity of TurkuTurku Finland;

  Department of Chest MedicineUniversité Catholique de LouvainYvoir Belgium;

  Department of PulmonologyCelal Bayar UniversityManisa Turkey;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 医学免疫学;
• 关键词

  mHealth; mobile technology; observational study; rhinitis; treatment;

  机译：MHEALT;移动技术;观察研究;鼻炎;治疗;